- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
July 30th, 2007
Biocon Ltd, India's leading biotechnology firm, has entered into an agreement with Neopharma, a leading Abu Dhabi-based pharma company owned by an Indian, to set up a joint venture (JV) in Dubai's biotech and research park - Dubaitech.
The new venture, christened Neobiocon, will manufacture and market bio-therapeutics in the Gulf region and fulfil the vision of the UAE's former president, late Sheikh Zayed Al Nahyan, to provide 'health for all' at affordable price, according to a company statement here Monday.
Neopharma plans to foray into European markets and work on nanotechnology-based products. Its facility is recognised as a regional contract manufacturing hub for European and Canadian firms.
|Related News Press|
Brightness-equalized quantum dots improve biological imaging October 5th, 2015
Sniffing out cancer with improved 'electronic nose' sensors October 2nd, 2015
Hopes of improved brain implants October 1st, 2015
New Nanomaterials Taking Research to Mexico, Possibly into Space September 29th, 2015
Research improves efficiency from larger perovskite solar cells October 6th, 2015
Pushing the limits of lensless imaging: At the Frontiers in Optics conference researchers will describe a custom-built ultrafast laser that could help image everything from semiconductor chips to cells in real time September 21st, 2015
Graphene Enhanced ARALDITE Resin Composite Materials September 14th, 2015